Nivolumab-induced cold agglutinin syndrome successfully treated with rituximab

Key Points Cold agglutinin syndrome is one of the rare immune-related adverse events of nivolumab. Rituximab should be considered for treatment of nivolumab-induced cold agglutinin syndrome.